Related Experiment Video

Updated: May 17, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

The significance of ubiquitin proteasome pathway in cancer development

Azmi Yerlikaya1, Mustafa Yöntem

  • 1Department of Biology, Art and Science Faculty, Dumlupınar University, Kütahya, 43100, Turkey. ayerlikaya@dumlupinar.edu.tr

Recent Patents on Anti-Cancer Drug Discovery
|October 16, 2012
PubMed

Insights

The ubiquitin proteasome pathway is crucial for protein degradation and cancer development. Inhibiting this pathway offers a promising strategy for novel cancer therapies.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncology

Background:

  • The ubiquitin proteasome pathway (UPP) is the primary intracellular system for protein degradation.
  • Dysregulation of UPP components is implicated in various cancers, affecting oncoproteins and tumor suppressors.
  • Alternative ubiquitin-independent degradation routes also exist, adding complexity to cellular protein homeostasis.

Purpose of the Study:

  • To review recent literature on the ubiquitin proteasome pathway's role in cancer.
  • To summarize patented inventions related to UPP inhibition for cancer treatment.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of patent databases for UPP-targeting inventions.

Main Results:

  • The UPP plays a dual role in cancer by stabilizing oncoproteins and degrading tumor suppressors.
  • Inhibitors targeting the UPP are under development for cancer therapy.
  • Patented inventions demonstrate significant interest in UPP-targeted cancer treatments.

Conclusions:

  • The ubiquitin proteasome pathway is a critical target for cancer therapy.
  • Developing specific UPP inhibitors holds promise for effective cancer treatment strategies.

More Related Videos

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations10:26

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations

Published on: November 7, 2019

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...